Cite
HARVARD Citation
Yoo, Y. et al. (2017). Glioma‐derived cancer stem cells are hypersensitive to proteasomal inhibition. EMBO reports. pp. 150-168. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yoo, Y. et al. (2017). Glioma‐derived cancer stem cells are hypersensitive to proteasomal inhibition. EMBO reports. pp. 150-168. [Online].